Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth…more
Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth…more
Latest RNS from Haleon plc
- director_pdmrDirector/PDMR Shareholding
- product_launchLaunch & price: $2bn three-tranche bond offering
- interim_results2026 Half Year Results
Analyst consensus: Buy
As of 22 Sept 2026, 18 analysts rate Haleon plc a Buy, with 61% buy ratings and a mean price target of 420p (range 315p–514p), +22% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 240p against a current price of 343p (-30%), based on EV/EBITDA.